Suppr超能文献

热休克蛋白27/白细胞介素-6轴通过正反馈回路协调巨噬细胞,促进口腔鳞状细胞癌的化疗耐药性、侵袭和迁移。

HSP27/IL-6 axis promotes OSCC chemoresistance, invasion and migration by orchestrating macrophages via a positive feedback loop.

作者信息

Qi Ying, Cao Juan, Jiang Mingjing, Lin Ying, Li Weibo, Li Bo

机构信息

Department of Oral Anatomy and Physiology, Hospital of Stomatology, Jilin Provincial Key Laboratory of Oral Biomedical Engineering, Jilin University, Changchun, 130021, China.

出版信息

Cell Biol Toxicol. 2025 Jan 28;41(1):36. doi: 10.1007/s10565-024-09983-1.

Abstract

Novel strategies to disrupt tumor progression have emerged from studying the interactions between tumor cells and tumor-associated macrophages (TAMs). However, the molecular mechanisms of interactions between tumor cells and TAMs underlying oral squamous cell carcinoma (OSCC) progression have not been fully elucidated. This study explored the molecular mechanism of the HSP27/IL-6 axis in OSCC chemoresistance, invasion, and migration. Here, we demonstrated the higher expression of HSP27 in OSCC cells. Paracrine HSP27 from OSCC cells enhanced chemoresistance, invasion, migration, and EMT in OSCC by inducing M2 polarization and IL-6 secretion in TAMs. HSP27 and IL-6 established a positive feedback loop between OSCC cells and M2 TAMs. TAMs-derived IL-6 orchestrated OSCC stemness and chemoresistance through upregulating β-catenin and CD44, and enhanced OSCC invasion, migration, and EMT via autocrine HSP27/TLR4 signaling. Collectively, HSP27/IL-6 axis facilitates OSCC chemoresistance, invasion, and migration by orchestrating macrophages through a positive feedback loop. We identify the regulatory mechanism underlying the interaction and crosstalk between OSCC cells and TAMs mediated by the HSP27/IL-6 axis. Targeting the HSP27/IL-6 axis could be a promising treatment strategy for OSCC patients, potentially controlling disease progression and improving prognosis and recurrence outcomes.

摘要

通过研究肿瘤细胞与肿瘤相关巨噬细胞(TAM)之间的相互作用,出现了破坏肿瘤进展的新策略。然而,口腔鳞状细胞癌(OSCC)进展过程中肿瘤细胞与TAM之间相互作用的分子机制尚未完全阐明。本研究探讨了HSP27/IL-6轴在OSCC化疗耐药、侵袭和迁移中的分子机制。在此,我们证明了HSP27在OSCC细胞中高表达。OSCC细胞旁分泌的HSP27通过诱导TAM中的M2极化和IL-6分泌,增强了OSCC的化疗耐药性、侵袭性、迁移能力和上皮-间质转化(EMT)。HSP27和IL-6在OSCC细胞与M2 TAM之间建立了正反馈回路。TAM来源的IL-6通过上调β-连环蛋白和CD44来调控OSCC干性和化疗耐药性,并通过自分泌HSP27/TLR4信号增强OSCC的侵袭、迁移和EMT。总的来说,HSP27/IL-6轴通过正反馈回路调控巨噬细胞,促进OSCC的化疗耐药性、侵袭和迁移。我们确定了由HSP27/IL-6轴介导的OSCC细胞与TAM之间相互作用和串扰的调控机制。靶向HSP27/IL-6轴可能是OSCC患者一种有前景的治疗策略,有可能控制疾病进展并改善预后和复发结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4bf/11775009/aa452d3da6d7/10565_2024_9983_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验